Literature DB >> 27864215

Atrophic exocrine pancreatic insufficiency associated with anti-PD1 therapy.

A Hoadley1, N Sandanayake2, G V Long3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27864215     DOI： 10.1093/annonc/mdw626

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Fatal myositis and spontaneous haematoma induced by combined immune checkpoint inhibitor treatment in a patient with pancreatic adenocarcinoma.

Authors:  Yuan Liu; Zhi Liu; Xuejun Zeng; Chunmei Bai; Lin Chen; Songbai Lin; Xinlun Tian
Journal:  BMC Cancer       Date:  2019-12-05       Impact factor: 4.430

2.  Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis.

Authors:  Alex S Hong; Naveed Sarwar; Robert D Goldin; Ameet Dhar; Lucia A Possamai
Journal:  Cureus       Date:  2022-07-05

Review 3.  Abdominal immune-related adverse events: detection on ultrasonography, CT, MRI and 18F-Fluorodeoxyglucose positron emission tomography.

Authors:  Mark A Anderson; Vikram Kurra; William Bradley; Aoife Kilcoyne; Amirkasra Mojtahed; Susanna I Lee
Journal:  Br J Radiol       Date:  2020-10-28       Impact factor: 3.039
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.